Journal Article

DZNE-2024-01420

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3.

Elter, T.-L. (First author)DZNE* ; Sturm, D. ; Santana, M. M. ; Schaprian, T.Extern* ; Raposo, M. ; Melo, A. R. V. ; Lima, M. ; Koyak, B.DZNE* ; Oender, D.DZNE* ; Grobe-Einsler, M.DZNE* ; Lopes, S. ; Silva, P. ; de Almeida, L. P. ; Giunti, P. ; Garcia-Moreno, H. ; Nethisinhe, S. ; de Vries, J. ; van de Warrenburg, B. P. ; van Gaalen, J. ; Synofzik, M.DZNE* ; Schöls, L.Extern* ; Reetz, K. ; Erdlenbruch, F. ; Jacobi, H. ; Infante, J. ; Riess, O. ; Klockgether, T.DZNE* ; group, E. s. (Collaboration Author) ; Faber, J. (Last author)DZNE* ; Hübener-Schmid, J. ; Timmann, D. (Contributor) ; Thieme, A. (Contributor)

2025
Springer Heidelberg

This record in other databases:  

Please use a persistent id in citations: doi:10.1007/s00415-024-12829-9

Abstract: Knowledge about the distribution and frequency of the respective haplotypes on the wildtype and mutant allele is highly relevant in the context of future gene therapy clinical studies in Spinocerebellar Ataxia Type 3, the most common autosomal dominantly inherited ataxia. Single nucleotide polymorphisms associated to the disease-causing gene, ATXN3, have been determined. We wanted to investigate the frequency and regional distribution of two intragenic single nucleotide polymorphisms (SNPs) in a large European SCA3 cohort and their relation to the clinical phenotype.The genotypes of the two polymorphisms at base pair positions 987 and 1118 of the ATXN3 were determined for their co-localization on the normal and expanded allele, respectively, in 286 SCA3 mutation carriers and 117 healthy controls from 11 European sites.The distribution of genotypes on the expanded allele differed from those of the wildtype allele of SCA3 mutation carriers and of healthy controls, and was mainly influenced by the regional origin. In our cohort, no particular clinical phenotype was associated with any specific haplotype.Our results confirm distinct allocations of SNPs associated to the expanded ATXN3, and accordingly the consideration of allele-specific therapies.

Keyword(s): Humans (MeSH) ; Machado-Joseph Disease: genetics (MeSH) ; Male (MeSH) ; Female (MeSH) ; Ataxin-3: genetics (MeSH) ; Polymorphism, Single Nucleotide (MeSH) ; Middle Aged (MeSH) ; Adult (MeSH) ; Nerve Tissue Proteins: genetics (MeSH) ; Repressor Proteins: genetics (MeSH) ; Aged (MeSH) ; Genotype (MeSH) ; Cohort Studies (MeSH) ; Nuclear Proteins: genetics (MeSH) ; Gene Frequency (MeSH) ; Haplotypes (MeSH) ; Young Adult (MeSH) ; ATXN3 ; ASO ; Polymorphism ; SCA3 ; SNP ; Spinocerebellar ataxia ; Ataxin-3 ; ATXN3 protein, human ; Nerve Tissue Proteins ; Repressor Proteins ; Nuclear Proteins

---

Contributing Institute(s):

1. Clinical Research Coordination (Clinical Research (Bonn))
2. Patient Studies (Bonn) (Patient Studies (Bonn))
3. Parkinson Genetics (AG Gasser)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2025

---

Database coverage:
; ; ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---